Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 6.38 | N/A |
| PEG Ratio (TTM) | 2.54 | N/A |
| P/S Ratio (TTM) | 2.43 | N/A |
| P/B Ratio (TTM) | 0.98 | N/A |
| P/FCF Ratio (TTM) | -60.81 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.18 | N/A |
| Price to 5YR AVG FCF Ratio | 11.10 | N/A |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.48% | N/A |
| ROE (TTM) | 16.06% | N/A |
| Net Profit Margin (TTM) | 38.22% | N/A |
| ROIC 5YR AVG | 25.81% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 75.88% | 40.14% | 44.73% |
| Revenue | 13.02% | 1.70% | 2,516.45% |
| Net Income | 75.54% | 45.88% | 47.07% |
| Cash Flow | 142.51% | 0.78% | 2.27% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.51 | N/A |
| Quick Ratio (TTM) | 0.51 | N/A |
| D/E Ratio (TTM) | 0.23 | N/A |
| Interest Coverage (TTM) | 1.61 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 2.63 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.62% | N/A |